<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211102052945N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-05-16</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Effects of inhalation of rosemary fragrance on alleviating pain</public_title>
      <acronym></acronym>
      <scientific_title>Effects of inhalation of rosemary fragrance on alleviating post orthopedic surgery pain(hip prosthesis placement) in ICU patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>64</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59931</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Table of random numbers using the site: www.randomization.com, Blinding description: The study is a three-way blind study that includes participants, evaluators and data analysts.</study_design>
      <phase>3</phase>
      <hc_freetext>Acute pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: All patients undergo anesthesia after pre-medication with 1 mg midazolam and 3 micrograms/kg fentanyl with 2 mg/kg propofol and 0.5 mg/kg atracurium. At the end of the surgery, the patient is admitted to the surgical ICU after extubation and without recovery and receives the same care. For all patients, at the beginning of admission and every 3 hours, pain determination is performed according to the NRS scoring system and if the score is more than 3, 0.05 mg/kg of intravenous morphine is prescribed every 10 minutes to reduce the pain score to less than 4. In addition to these treatments, in the intervention group, a gauze impregnated with 5 drops of 3% rosemary essential oil (about one cc of essential oil on a 5*5 cm gauze) will be pinned to the patient's shirt and will be renewed every three hours. The score of pain and the required dose of morphine will be recorded every 3 hours for 24 hours. Intervention 2: Control group: All patients undergo anesthesia after pre-medication with 1 mg midazolam and 3 micrograms/kg fentanyl with 2 mg/kg propofol and 0.5 mg/kg atracurium. At the end of the surgery, the patient is admitted to the surgical ICU after extubation and without recovery and receives the same care. For all patients, at the beginning of admission and every 3 hours, pain determination is performed according to the NRS scoring system and if the score is more than 3, 0.05 mg/kg of intravenous morphine is prescribed every 10 minutes to reduce the pain score to less than 4. In addition to these treatments, in the control group, a gauze impregnated with 5 drops of sweet almond oil (about one cc of oil on a 5*5 cm gauze) will be pinned to the patient's shirt and will be renewed every three hours. The score of pain and the required dose of morphine will be recorded every 3 hours for 24 hours.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is We wait to complete study</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Arash Peivandi Yazdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Anesthesia, Imam Reza Hospital, Ibne Sina Street, Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3885 3858</telephone>
        <email>peivandia@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Arash Peivandi Yazdi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Anesthesia, Imam Reza Hospital, Ibne Sina Street, Mashhad</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3885 3858</telephone>
        <email>peivandia@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged 18-70 year old
ASA class III maximum
Candidate for at least 24 hours stay in ICU
Post orthopedic surgery and implantation of hip prosthesis</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Drug addiction
Pregnancy and lactation
Dissatisfaction
Allergy to rosemary
Any length of surgery or complications during and after surgery and leaving the same care
Routine user of any analgesic in the period of 2 months before surgery
Uncontrolled high blood pressure
Epilepsy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>R52.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute pain, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: All patients undergo anesthesia after pre-medication with 1 mg midazolam and 3 micrograms/kg fentanyl with 2 mg/kg propofol and 0.5 mg/kg atracurium. At the end of the surgery, the patient is admitted to the surgical ICU after extubation and without recovery and receives the same care. For all patients, at the beginning of admission and every 3 hours, pain determination is performed according to the NRS scoring system and if the score is more than 3, 0.05 mg/kg of intravenous morphine is prescribed every 10 minutes to reduce the pain score to less than 4. In addition to these treatments, in the intervention group, a gauze impregnated with 5 drops of 3% rosemary essential oil (about one cc of essential oil on a 5*5 cm gauze) will be pinned to the patient's shirt and will be renewed every three hours. The score of pain and the required dose of morphine will be recorded every 3 hours for 24 hours.</i_keyword>
      <i_keyword>Control group: All patients undergo anesthesia after pre-medication with 1 mg midazolam and 3 micrograms/kg fentanyl with 2 mg/kg propofol and 0.5 mg/kg atracurium. At the end of the surgery, the patient is admitted to the surgical ICU after extubation and without recovery and receives the same care. For all patients, at the beginning of admission and every 3 hours, pain determination is performed according to the NRS scoring system and if the score is more than 3, 0.05 mg/kg of intravenous morphine is prescribed every 10 minutes to reduce the pain score to less than 4. In addition to these treatments, in the control group, a gauze impregnated with 5 drops of sweet almond oil (about one cc of oil on a 5*5 cm gauze) will be pinned to the patient's shirt and will be renewed every three hours. The score of pain and the required dose of morphine will be recorded every 3 hours for 24 hours.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Patients' pain score based on NSR questionnaire. Timepoint: Measure the patient's pain at the time of admission to the ICU and every 3 hours for up to 24 hours. Method of measurement: Numeric Rating Scale questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Amount of morphine used. Timepoint: If necessary, once every ten minutes. Method of measurement: Record the prescribed drug by dose.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-19</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Ghoreishi building, Daneshgah street, Mashhad Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
